Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 461 - 480 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »
Reset 

Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ)

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Enzymatica AB

Ascletis' Ravidasvir NDA Proposed for Priority Review by the CFDA

HANGZHOU and SHAOXING, China, Oct. 18, 2018 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK) announces today the New Drug Application (NDA) of Ravidasvir is on the List of Proposed Priority Review, according to the public notification by the China Food and Drug Administration (CFDA) on Oct 17(th),... Read more ››

By: PR Newswire Association LLC. - 18 Oct 2018

Luminex Corporation to Acquire MilliporeSigma's Flow Cytometry Portfolio

AUSTIN, Texas, Oct. 18, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has signed a definitive agreement to acquire MilliporeSigma's flow cytometry portfolio for $75 million, consisting of approximately $69.9 million to be paid under a Stock and Asset... Read more ››

By: PR Newswire Association LLC. - 18 Oct 2018
Related companies:  Luminex Corporation

The European Society of Endocrinology Meets With European Parliament Members to Discuss Limiting the Socioeconomic Impact of Osteoporosis in Europe

MILAN, October 18, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Oct 2018

Sysmex Inostics' OncoBEAM(TM) Platform Demonstrates Superior Detection of Clinically-relevant Mutations for Therapy Selection and Molecular Monitoring for Lung and Colon Cancers

HAMBURG, Germany, October 18, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Oct 2018
Related companies:  Sysmex Inostics Inc.

Valens announces formation of advisory board

KELOWNA, BC, Oct. 18, 2018 /CNW/ - Valens GroWorks Corp. (CSE: VGW) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services utilizing proprietary extraction processes is pleased to announce that it has formed an... Read more ››

By: PR Newswire Association LLC. - 18 Oct 2018

RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada

The National Sciences and Engineering Research Council of Canada has funded a University of Victoria project aimed at collaborating with RepliCel to optimize cell culture and manufacturing technologies

Read more ››
By: PR Newswire Association LLC. - 18 Oct 2018
Related companies:  RepliCel Life Sciences Inc.

Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018

Aclaris Announces Pricing of Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Aclaris Therapeutics, Inc.

Novartis delivered strong growth and innovation during the third quarter, including progressing advanced therapy platforms to drive future growth

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Novan, Inc.

Novartis announces planned acquisition of Endocyte to expand expertise in radiopharmaceuticals and build on commitment to transformational therapeutic platforms

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Novan, Inc.

Innovent Announces First Patient Dosed in a Phase I Clinical Trial of Anti-CTLA-4 Monoclonal Antibody

SUZHOU, China, Oct. 18, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announces that the first patient has been dosed in a phase I clinical trial of anti-CTLA-4 (Cytotoxic T Lymphocyte-associated... Read more ››

By: PR Newswire Association LLC. - 18 Oct 2018
Related companies:  Innovent Biologics Co., Ltd.

Kazia Raises A$3.4 Million to Progress R&D Programs

SYDNEY, Oct. 18, 2018 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce the completion of a placement of KZA shares, primarily to sector-specialist institutional investors in Australia and internationally,... Read more ››

By: PR Newswire Association LLC. - 18 Oct 2018

UCB Accelerates Anti-FcRn Rozanolixizumab in Myasthenia Gravis Into Confirmatory Development Phase

BRUSSELS, October 18, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Oct 2018
Related companies:  UCB Pharma GmbH

The Impact of Fragility Fractures due to Osteoporosis is Being Ignored

BRUSSELS, Belgium, October 18, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Oct 2018
Related companies:  UCB INC. (US)

2018 Rock Health Summit Opens with Panel Featuring DotLab CEO

SAN FRANCISCO, Oct. 18, 2018 /PRNewswire/ -- On Tuesday, DotLab CEO Heather Bowerman spoke on the opening panel of the 2018 Rock Health Summit. Rock Health... Read more ››

By: PR Newswire Association LLC. - 18 Oct 2018
Related companies:  Rock Health partners | DotLab

PhaseBio Announces Pricing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  PhaseBio Pharmaceuticals Inc.

Abattis Bioceuticals Celebrates Legalization

Read more ››
By: Nasdaq / GlobenewsWire - 18 Oct 2018
Related companies:  Abattis Bioceuticals Corporation

Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

LONDON, Oct. 17, 2018 /PRNewswire/ -- Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa

Download the full report: Read more ››

By: PR Newswire Association LLC. - 18 Oct 2018

Digital Landscape: Asthma

LONDON, Oct. 17, 2018 /PRNewswire/ -- Digital Landscape: Asthma

Summary
"Digital Landscape: Asthma", analyzes digital activities undertaken by pharma industry in support of therapies for asthma.

Download the full report: Read more ››

By: PR Newswire Association LLC. - 18 Oct 2018
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »
to the top ↑